The Full Wiki

More info on Pagibaximab

Pagibaximab: Wikis


Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.


From Wikipedia, the free encyclopedia

Pagibaximab ?
Monoclonal antibody
Source Chimeric
Target Staphylococcal lipoteichoic acid
CAS number 595566-61-3
ATC code none
PubChem  ?
Chemical data
Formula C 6462H9996N1728O2028S54  
Mol. mass  ?
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.  ?
Legal status
Routes  ?

Pagibaximab is a chimeric monoclonal antibody for the prevention of staphylococcal sepsis in infants with low birth weight. As of July 2009, it is undergoing Phase I/II clinical trials.[1]


  1. ^ Weisman, LE; Thackray; Garcia-Prats; Nesin; Schneider; Fretz; Kokai-Kun; Mond et al. (2009). "Phase 1/2 double-blind, placebo-controlled, dose escalation, safety, and pharmacokinetic study of pagibaximab (BSYX-A110), an antistaphylococcal monoclonal antibody for the prevention of staphylococcal bloodstream infections, in very-low-birth-weight neonates". Antimicrobial agents and chemotherapy 53 (7): 2879–86. doi:10.1128/AAC.01565-08. PMID 19380597.  


Got something to say? Make a comment.
Your name
Your email address